UK practice guidance (UPG1) - Hypercalcemia of malignancy
This post addresses a specific question on hypercalcemia of malignancy visavis maximal calcitonin dosing, while providing advice regarding the use of prophylactic anti-emetics and warning against the development of tachyphylaxis. This represent the first in a series of posts designed to reflect clinical practice guidance from UK based trusts, which are listed in thereference.
Authors
- Rahul Arora
Institutions
- M S Ramaiah Memorial Hospital (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-06-24
- DOI
- https://doi.org/10.5281/zenodo.20828334
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00